Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma

This review article will be focused on the discussion of the most promising immunoproteasome specific inhibitors which have been developed in recent years. Particular attention will be devoted to the description of their mechanism of action, their structure-activity relationship, and their potential application in therapy.